Prior studies have indicated a requirement for the PDZ domain-containing protein, Na Inhibition of the renal apical membrane Na ϩ /H ϩ exchanger 3 (NHE3) 1 by cAMP-dependent protein kinase (PKA) requires the presence of an additional protein co-factor called the Na ϩ /H ϩ Exchanger Regulatory Factor (NHERF) (1). NHERF contains two tandem PSD-95/Dlg/ZO-1 (PDZ) domains and functions in a signal-complex of proteins, including ezrin, PKA, and NHE3 (1-3). This multiprotein complex facilitates the phosphorylation of NHE3 and the acute down-regulation of its activity (1-3). Subsequent to the elucidation of the role of NHERF in the regulation of NHE3, a role for this protein in the regulation of the activity of other transporters has been proposed, and it has been suggested that the signal-complex model of regulation of renal transport proteins may be more common than currently appreciated (4). In the renal proximal tubule, there is an intimate relation between the apical membrane Na ϩ /H ϩ exchanger and the basolateral membrane sodium bicarbonate co-transporter (NBC). These two transporters are regulated in parallel in response to a variety of experimental maneuvers, hormones, and second messengers (5-9). The coordinated regulation of NHE3 and NBC appears to be the result of specific regulatory mechanisms and not merely the consequence of the availability of ion substrates for the transporters. NBC, like NHE3, is regulated by stimuli that raise intracellular cAMP (8, 9). In association with Bernardo et al. (10), we have previously provided evidence that PKA-mediated inhibition of renal NBC requires NHERF. It is not known, however, if NHERF functions to form a signal-complex that regulates NBC activity or if NBC itself is phosphorylated by PKA. To study the relation between NBC and NHERF, wild-type, truncated, and mutated forms of NHERF were expressed in BSC-1 cells to determine if NHERF binds NBC, if NHERF is required for the phosphorylation of NBC, if the phosphorylation of NHERF is required for NBC regulation, and if NBC requires tethering to the actin cytoskeleton to be regulated by cAMP. The results indicate that the interaction between NHERF and NBC differs from the interactions between NHERF and NHE3. Although the ezrin-radixin-moesin (ERM) binding domain of NHERF is required for cAMP regulation of NBC, NHERF does not bind to NBC or facilitate cAMP-mediated phosphorylation of NBC. Moreover, 15-min treatment of the cells with cAMP does not affect the cell surface expression NBC. It is suggested that cAMP-mediated inhibition of NBC is the result of a biochemical modification of the NBC transporter by a process that requires NHERF but is not associated with phosphorylation of the transporter itself.
Inhibition of the renal apical membrane Na ϩ /H ϩ exchanger 3 (NHE3) 1 by cAMP-dependent protein kinase (PKA) requires the presence of an additional protein co-factor called the Na ϩ /H ϩ Exchanger Regulatory Factor (NHERF) (1) . NHERF contains two tandem PSD-95/Dlg/ZO-1 (PDZ) domains and functions in a signal-complex of proteins, including ezrin, PKA, and NHE3 (1) (2) (3) . This multiprotein complex facilitates the phosphorylation of NHE3 and the acute down-regulation of its activity (1) (2) (3) . Subsequent to the elucidation of the role of NHERF in the regulation of NHE3, a role for this protein in the regulation of the activity of other transporters has been proposed, and it has been suggested that the signal-complex model of regulation of renal transport proteins may be more common than currently appreciated (4) . In the renal proximal tubule, there is an intimate relation between the apical membrane Na ϩ /H ϩ exchanger and the basolateral membrane sodium bicarbonate co-transporter (NBC). These two transporters are regulated in parallel in response to a variety of experimental maneuvers, hormones, and second messengers (5) (6) (7) (8) (9) . The coordinated regulation of NHE3 and NBC appears to be the result of specific regulatory mechanisms and not merely the consequence of the availability of ion substrates for the transporters. NBC, like NHE3, is regulated by stimuli that raise intracellular cAMP (8, 9) . In association with Bernardo et al. (10) , we have previously provided evidence that PKA-mediated inhibition of renal NBC requires NHERF. It is not known, however, if NHERF functions to form a signal-complex that regulates NBC activity or if NBC itself is phosphorylated by PKA. To study the relation between NBC and NHERF, wild-type, truncated, and mutated forms of NHERF were expressed in BSC-1 cells to determine if NHERF binds NBC, if NHERF is required for the phosphorylation of NBC, if the phosphorylation of NHERF is required for NBC regulation, and if NBC requires tethering to the actin cytoskeleton to be regulated by cAMP. The results indicate that the interaction between NHERF and NBC differs from the interactions between NHERF and NHE3. Although the ezrin-radixin-moesin (ERM) binding domain of NHERF is required for cAMP regulation of NBC, NHERF does not bind to NBC or facilitate cAMP-mediated phosphorylation of NBC. Moreover, 15-min treatment of the cells with cAMP does not affect the cell surface expression NBC. It is suggested that cAMP-mediated inhibition of NBC is the result of a biochemical modification of the NBC transporter by a process that requires NHERF but is not associated with phosphorylation of the transporter itself.
EXPERIMENTAL PROCEDURES

Construction and Use of NHERF Expression
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ʈ To whom correspondence should be addressed: Dept. of Medicine, School of Medicine, University of Maryland, 22 S. Greene St., Rm. N3W143, Baltimore, MD 21201. Tel.: 410-706-1555; Fax: 410-706-4195; E-mail: eweinman@medicine.umaryland.edu. 1 The abbreviations used are: NHE3, Na ϩ /H ϩ exchanger 3; PKA, cAMP-dependent protein kinase; NHERF, Na ϩ /H ϩ exchanger regulatory factor; PDZ, PSD-95/Dlg/ZO-1; NBC, Na ϩ -HCO 3 Ϫ co-transporter; ERM, ezrin-radixin-moesin; PCR, polymerase chain reaction; BCECF-AM, 2Ј,7Ј-bis(carboxyethyl)-5,6-carboxyfluorescein; EIPA, ethyl isopro-lack endogenous NHERF (10). Wild-type, truncated, and mutated forms of mouse and rabbit NHERF cDNAs were cloned into the pcDNA3.1/Hygroϩ vector and transfected into the BSC-1 cells using Lipofectin (Life Technologies, Inc.). Cells resistant to 600 units/ml hygromycin were selected through eight passages prior to study. Transfected BSC-1 cells were maintained at 37°C in a humidified atmosphere with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) fetal calf serum, penicillin (100 units/ml), streptomycin (100 mg/ml), and 600 unit/ml hygromycin. Cells were grown to confluence in serum, split, and regrown to sub-confluency in the presence of serum prior to analysis.
Full-length and truncated forms of mouse NHERF were made using existing restriction sites and/or PCR with the Zero Blunt TOPO PCR kit (Invitrogen) (2, 3) . Constructs encoding N-terminal mNHERF-(1-126), C-terminal mNHERF-(116 -355), full-length mNHERF-(1-355), and mNHERF-(1-325) that eliminated the proposed ezrin-radixin-moesinmerlin (ERM) binding domain were inserted in-frame into the pcDNA3.1/Hygroϩ vector (2, 3). The mutant form of rabbit NHERF was made using the MORPH mutagenesis kit (5 Prime 3 3 Prime, Inc., Boulder, CO), and the mutation was confirmed by double-stranded sequencing (2) . Serine residues 287, 289, and 290 were mutated to alanine residues using an oligonucleotide of the following sequence: 5Ј-GCTGGTGTCAGCGGCGGCGGCTCTTGC-3Ј. For each form of NHERF tested, several groups of BCS-1 cells were transfected separately. Each group was handled and studied independently. Mixed cell cultures expressing an individual form of NHERF did not differ from like cultures, and the results were pooled for analysis.
NBC Transport Assay-NBC activity was assayed in BSC-1 cells grown on glass coverslips using the pH-sensitive fluorescent dye, 2Ј,7Ј-bis(carboxyethyl)-5,6-carboxyfluorescein (BCECF-AM) (10) . Cells were serum-deprived for 12-20 h and then loaded with 12 M BCECF-AM in an assay buffer of 20 mM HEPES, pH 7.4, containing 90 mM sodium gluconate, 20 mM (NH 4 ) 2 SO 4 , 5 mM potassium gluconate, 1 mM MgSO 4 , 10 mM tetramethyl 2mmonium-PO 4 , 5 mM glucose, 20 mM mannitol, and 2 mM CaSO 4 for 30 min at room temperature. The cells were then perfused with the same solution not containing BCECF for 1 min. The cells were acidified with a solution containing 115 mM potassium gluconate, 9 mM HEPES, 1 mM KH 2 PO 4 , 0.5 mM MgSO 4 , 25 mM choline bicarbonate, 10 mM glucose, and 2 mM CaSO 4 for 10 min. NBC activity was determined using a solution containing 5 mM potassium gluconate, 9 mM HEPES, 1 mM KH 2 PO 4 , 0.5 mM MgSO 4 , 20 mM NaHCO 3 , 110 mM sodium gluconate, 10 mM glucose, and 2 mM CaSO 4 . Ethyl isopropyl amiloride (EIPA), 50 M, was added to all perfusion solutions to inhibit Na ϩ /H ϩ exchanger activity. In initial experiments, chloride-containing solutions were compared with sulfate containing solutions to determine if BSC-1 cells expressed a sodium-dependent or sodium-independent chloride-bicarbonate exchanger. BCECF fluorescence was measured at excitation wavelengths of 500 and 440 nm and an emission wavelength of 530 nm. The NH 4 SO 4 pulse was used to achieve an initial pH i of 6.0 -6.2. Four or more regions of interest encompassing groups of cells were delineated on each coverslip. The results from each region were averaged to constitute a single experimental observation. NBC activity, expressed as ⌬pH i /s, represented the initial slope of transport activity measured within the first 20 s of sodium-dependent pH i recovery. Over this brief time period, the relationship between pH i and time was essentially linear. To analyze the effects of cAMP on NBC activity, cells were pretreated with 100 M 8-bromo-cAMP during the final 15 min of dye loading and continuously throughout the perfusion process. At the end of each experiment, the cells were equilibrated in pH clamp media containing 20 mM HEPES, 20 mM MES, 110 mM KCl, 14 mM NaCl, 1 mM MgSO 4 , 1 mM CaCl 2 , 10 mM tetramethyl 2mmonium-PO 4 , 25 mM glucose, and 10 M nigericin at pH 6.0 and 7.3. Preliminary experiments established that the ratio values were linear with pH between these values. All measurements were made on cells at the same passage on the same day.
Metabolic Labeling of NHERF and NBC in BSC-1 Cells-To determine the in vivo phosphorylation of NBC, cells were washed with phosphate-free Dulbecco's modified Eagle's medium and labeled in vivo for 4 h using the same media containing 2.5 mCi of [␥-
32 P]orthophosphate. At the end of the incubation, half of the cells were treated with 100 M 8-bromo-cAMP for 15 min. Control and cAMP treated cells were scraped and resuspended in 500 l of a solution containing 60 mM Hepes/Tris, pH 7.4, 150 mM NaCl, 3 mM KCl, 25 mM sodium pyrophosphate, 5 mM EDTA, 5 mM EGTA, 1 mM Na 3 VO 4 , 50 mM NaF, and protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride, 1 mM phenanthroline, and 1 mM iodoacetamide (IP buffer)). Cells were collected by centrifugation for 10 min at 12,000 ϫ g and resuspended in IP buffer containing 1% Triton X-100, lysed by being drawn through a 27-gauge needle, agitated on a rotating rocker at 4°C for 30 min, followed by centrifugation at 12,000 ϫ g for 30 min to remove insoluble cellular debris. The supernatants were first precleared with Protein A-Sepharose CL4B beads by rocking for 1 h. The beads were then spun down, and the supernatants were incubated overnight with an anti-NBC polyclonal antibody. Protein A-Sepharose beads previously treated with BSC-1 cell extract solubilized by 1% Triton X-100 were then added and allowed to rock for an additional 2 h. The beads were eluted by boiling in 70 l of Laemmli SDS-sample buffer. The phosphoprotein corresponding to NBC was identified on 10% SDS-polyacrylamide gels and autoradiography.
To extend these observations, an in vitro "back-phosphorylation" assay was employed to assess PKA-mediated phosphorylation of NBC. The rationale for this approach is that in vivo activation of PKA by cAMP should phosphorylate specific serine residue(s) in the C terminus of NBC and render them unavailable for back-phosphorylation in vitro by PKA. Wild-type or BSC-1 cells expressing mNHERF-(1-355) were studied under basal conditions or after treatment of the cells with 100 M 8-bromo-cAMP for 15 min. The immunoprecipitation procedures were performed as indicated above using Protein A-Sepharose beads. Samples were eluted from the beads with 100 l of 30 mM glycine HCl, pH 2.8, and immediately neutralized by the addition of 10 l of 1 M Tris, pH 11. Samples were phosphorylated at pH 7.4 for 10 min at 30°C in the presence of 21 mM glycine, 100 mM Tris, pH 7.4, 50 mM MgCl 2 , 180 units of the catalytic subunit of PKA (Promega), and 50 mCi of [␥-
32 P]ATP. The reaction was terminated by boiling in Laemmli buffer and run on 10% SDS-polyacrylamide gel electrophoresis. The proteins were transferred to nitrocellulose, and the phosphoproteins were visualized by autoradiography. After autoradiography, Western immunoblotting using polyclonal anti-NBC antibodies were performed to assess sample loading of the gels, and the immune complexes were detected by Enhanced Chemical Luminescence (ECL) (Amersham Pharmacia Biotech, Arlington Heights, III).
Immunoprecipitation of NHERF and NBC-Co-immunoprecipitation experiments were performed using cell lysates from BSC-1 cells expressing wild-type mNHERF-(1-355) in the absence or presence of treatment with 100 M 8-bromo-cAMP for 15 min. The lysates were split, and proteins were immunoprecipitated using either an anti-NBC antibody or anti-NHERF antibody following the protocol outline above. The individual antibodies were conjugated to Protein A-Sepharose beads using disuccinimidyl suberate. NBC and NHERF were resolved on 10 and 6% polyacrylamide gels, respectively.
Yeast Two-hybrid Analyses-A yeast two-hybrid screen was performed using mNHERF-(1-355), mNHERF-(1-126), or mNHERF-(116 -355) as bait and NBC or the C-terminal 700 bp of rabbit NHE3 as prey. PCR-amplified constructs were subcloned into pLexA or pB42AD vectors (CLONTECH). All plasmid constructs were verified by sequencing. Yeast bait and prey plasmids were cotransformed into the yeast reporter strain EGY48[p8op-lacZ] and plated on synthetic dropout plates [Ϫhis, Ϫura, Ϫtrp] to select for transformants. Yeast colonies were harvested and lysed, and activity was determined using a luciferase assay. Activity was calculated as units/A 600 . Colonies expressing only the bait or prey were run as controls with each screen. These colonies expressed only minimal activity. The results are expressed as the ratio (-fold increase) of activity in the experimental colonies divided by the highest value of the appropriate control yeast colonies. Western immunoblotting was used to confirm expression of the fusion proteins.
Immunolocalization and Surface Expression of NBC-Cell surface expression of NBC was determined in mNHERF-(1-355)-expressing BSC-1 cells under control conditions or after 15 min of treatment with 100 M 8-bromo-cAMP. Cell surface proteins were biotinylated at 4°C using a borate buffer containing sulfosuccinimide-2-(biotinamido)ethyl-1,3-dithioproprionate-biotin, scraped, solubilized with Triton X-100, and centrifuged at 12,000 ϫ g (11) . A portion of the supernatant was separated, and the remainder was incubated with avidin-agarose. The 
TABLE II Yeast two-hybrid analysis of NHERF and NBC association
Yeast two-hybrid analysis of the interaction between NHERF and NBC. The bait was prepared by ligating NHERF-(1-355), representing full-length mouse NHERF; NHERF-(1-126), representing mouse PDZ I; or NHERF-(116 -355), representing mouse PDZ II and the C terminus to pLexA. The prey was prepared by ligating full-length human NBC1 or a terminal 700-bp fragment of rabbit NHE3 to pB42AD. Yeast lysates were assayed for ␤-galactosidase activity using a luciferase assay. Yeast-expressing bait or prey alone was run as controls, and the results (mean Ϯ S.E.) are expressed as -fold increase (experimental/control). n ϭ 3 for all groups. avidin-agarose beads were washed in buffer, and the bound proteins were solubilized and heated gently to yield the surface fraction. The fractions were run on SDS-polyacrylamide gel electrophoresis and transferred to Immobilon membranes, and Western analysis was performed using anti-NBC antibodies. Multiple antibodies to NBC1 were utilized. The following antigens were used to generate polyclonal antibodies in rabbits: a polypeptide representing amino acids 153-172 and 1016 -1035 of rat NBC1, a polypeptide representing the terminal 18 amino acids of human NBC1, a maltose binding protein (MBP) fused to amino acids 990 -1035 of rat NBC1, and a MBP fused to amino acids 338 -391 of rat NBC1. In addition, antibodies raised in guinea pig against both MBP fusion proteins were used. All of the antibodies yielded a single band of ϳ120 kDa using BSC-1 cell lysates, and comparable results were obtained with each antibody. Preliminary studies established that the signal for each antibody was ablated by preincubation of the antibody with the polypeptide antigen used to generate the antibody. Unless otherwise indicated, studies were performed using the antibody to the terminal 18 amino acids of human NBC1. Western immunoblots of BSC-1cell lysates were performed using antibodies to NBC1 or NHERF (2). Control and cAMP-treated (100 M 8-bromo-cAMP for 15 min) BSC-1 cells grown on coverslips were fixed in 3.7% paraformaldehyde for 30 min followed by washing and quenching of aldehyde groups with 50 mM NH 4 Cl. Cells were then permeabilized by 0.1% Triton X-100 for 30 min and treated with 6 M guanidine for 10 min to unmask antigenic sites (12) . Slides were incubated with a guinea pig or rabbit polyclonal antibody to NBC and an antibody to rabbit NHERF or ezrin (SC-6407, Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C. After washing, they were incubated with secondary antibody for 2 h at 4°C. The secondary antibodies were coupled to Alexa 488 or 568 dyes (Molecular Probes, Eugene, OR) diluted 1:100. Specimens were examined with a Zeiss LSM410 confocal microscope. Protein concentrations were determined by the method of Lowry et al. (13) . The results were analyzed by analysis of variance (14) . (Fig. 1A) . Also shown in Fig. 1 is the inability to detect a cross-reacting antigen to an anti-rabbit NHERF polyclonal antibody in wildtype BSC-1 cells and the ready expression of mNHERF-(1-355) in the transfected cells (Fig. 1B) . Immunoblots of cell lysates expressing the other truncated and mutated forms of NHERF demonstrated NHERF bands of the appropriate size but no change in the endogenous expression of NBC (data not shown). NBC is expressed in the basolateral surface of the BSC-1 cells (see Figs. 4 and 6) where it co-localizes with Na ϩ -K ϩ -ATPase (not shown). Ezrin is expressed predominantly at the apical membrane but, at high resolution, can be seen throughout the BSC-1 cells. Preliminary experiments indicated that NBC also localizes to the basolateral membranes of rat kidney (not shown).
RESULTS
Fig. 1 indicates that BSC-1 cells express NBC1
NBC Activity in BSC-1 Cells-In prior studies using BSC-1 cells, removal of sodium from a perfusion solution that contained amiloride resulted in a decrease in pH i of a modest and variable degree (10) . In the present experiments, cells were prepulsed using either NH 4 Cl or NH 4 SO 4 to lower pH i to 6.0 -6.2 to maximally stimulate transporters activated by intracellular acidosis. In the absence of CO 2 and bicarbonate, pH i recovered rapidly in the presence of sodium. The sodium-dependent pH i recovery was totally inhibited by amiloride (1 mM) or EIPA (50 M) indicating the operation of a Na ϩ /H ϩ exchanger. Accordingly, all ensuing experiments were conducted in the presence of 50 M EIPA. After acidification, the pH i remained unchanged or tended to drift slowly over several minutes to more alkaline values when the cells were perfused with a sodium-free choline bicarbonate/potassium gluconate solution containing EIPA (Fig. 2A) . This "drift" was not apparent in all cells and did not differ between cells prepulsed with NH 4 Cl or NH 4 SO 4 . Even in cells that demonstrated this slow upward pH shift, the rate was orders of magnitude slower than that observed in the presence of sodium, was not affected by cAMP, and, for the purposes of these experiments, was not considered further in the calculation of the rates of NBC transport. As shown in Fig. 2A , there was a rapid rise in pH i when the cells were perfused with sodium bicarbonate. To determine if BSC-1 cells contained a sodium-dependent anion exchanger, the rate of sodium-dependent pH i recovery was determined using chloride-containing or chloride-free solutions. The total duration of exposure to chloride free solutions was 35-45 min. Sodium-dependent pH i recovery averaged 0.053 Ϯ 0.004 ⌬pH i /s when the all-incubating, prepulse, and perfusion solutions contained chloride and 0.059 Ϯ 0.005 ⌬pH i /s (n ϭ 6) and when the solutions contained sulfate but no chloride (p ϭ NS). Taken together, these findings indicate that BSC-1 cells possess an amiloride-sensitive Na ϩ /H ϩ exchanger and a sodium bicarbonate symporter. They do not exhibit a sodium-independent chloride/bicarbonate exchanger, a sodium-dependent anion exchanger, or a potassium-dependent mechanism for transfer of base equivalents. These finding are in accord with prior studies of Jentsch et al. (15) . Accordingly, NBC activity was taken as the rate of sodium-dependent pH i recovery in cells preincubated in chloride-free solutions, prepulsed with NH 4 SO 4 , and perfused with a chloride-free sodium bicarbonate solution containing EIPA. To study the role of NHERF phosphorylation in cAMP-mediated inhibition of NBC, rabbit NHERF containing serine to alanine mutations at positions 287, 289, and 290 was expressed. Prior studies have indicated that rNHERF S287A/ S289A/S290A is not a phosphoprotein in vivo and is not phosphorylated by PKA (2) . Preliminary studies established that wild-type rabbit NHERF was equivalent to mouse NHERF in supporting cAMP inhibition of NBC activity in BSC-1 cells. In cells expressing rabbit NHERF S287A/S289A/S290A, NBC activity averaged 0.043 Ϯ 0.004 ⌬pH i /s and 0.026 Ϯ 0.002 ⌬pH i /s in the absence and presence of cAMP, respectively (n ϭ 8, p Ͻ 0.05). (Table II) . This level of interaction was low as compared with the 300-fold or higher increase in reporter gene activity when NHERF and the Cterminal tail of NHE3 were assayed concurrently. Given that the conformation of membrane proteins such as NBC may not reflect well their interactions with binding proteins in yeast nuclei, co-immunoprecipitation experiments were undertaken to provide a cellular assay for possible direct interactions between the proteins in BSC-1 cells. Immunoprecipitation of NBC from mNHERF-(1-355)-expressing BSC-1 cells did not result in the co-immunoprecipitation of NHERF (Fig. 3A) . In a similar manner, NHERF immunoprecipitates did not contain NBC (Fig. 3B) . Treatment of the cells with cAMP had no effect on the pattern of protein recoveries. Using the guinea pig antibody to amino acids 1016 -1035 of rat NBC1 and a rabbit antibody to NHERF, mNHERF-(1-355)-expressing BSC-1 cells were examined by confocal microcopy. NHERF was abundantly expressed and was prominent throughout the cell, including the apical and basolateral membranes, and the cytosol. NBC, on the other hand, was seen predominantly in the basolateral membrane. Fig. 4 shows confocal images from planes near the basolateral surface of the cells. In this figure, NHERF is shown in green and NBC in red. There was no merged color indicative of co-localization of the two proteins. Treatment of the cells with cAMP did not alter the pattern of expression of NHERF or NBC. These findings were confirmed using a monoclonal antibody to NHERF and the rabbit polyclonal antibody to amino acids 153-172 and 1016 -1035 of rat NBC1 (not shown).
Structure-Function Analysis of NHERF as a Regulator of NBC Activity in BSC-1 Cells-Transfection
Analysis of NBC/NHERF
Phosphorylation of NBC in BSC-1 Cells-The biochemical hall-mark of cAMP inhibition of NHE3 is phosphorylation of the transporter itself (2, 3, 16, 17) . To determine if NBC was phosphorylated by cAMP, wild-type and mNHERF-(1-355)-expressing BSC-1 cells were metabolically labeled using [ 32 P]orthophosphate. NBC immunoprecipitated as a phosphoprotein from both wild-type and NHERF-expressing unstimulated cells, but the phosphorylation of NBC was not increased in either of these cell types by treatment with cAMP (Fig. 5A) . To study PKA phosphorylation of NBC directly, NBC was immunoprecipitated from wild-type and   FIG. 4. mNHERF-(1-355) -expressing BSC-1 cells were fixed and doublelabeled using a guinea pig antibody to NBC1 (red) and a rabbit antibody to NHERF (green). Confocal images from planes near the basolateral surface of the cells were obtained from control cells (ϪcAMP) and from cells treated with 100 M 8-bromo-cAMP for 15 min (ϩcAMP). No merged color is observed in any sections, indicating that the two proteins do not co-localize.
mNHERF-(1-355)-expressing BSC-1 cells. In the presence or absence of prior in vivo treatment of the cells with cAMP for 15 min, immunoprecipitated NBC was not phosphorylated by PKA in vitro in either cell line (Fig. 5B) . The autophosphorylation of PKA was run as a positive control to ensure that the PKA was active (not shown). These studies indicate that, although NBC is a phosphoprotein, its phosphorylation is not increased by cAMP and that NBC is not a substrate for PKA-mediated phosphorylation.
Cell Surface Expression of NBC in BSC-1 Cells-Alterations
in transport activity may be the result of a modification of transporters already resident in the plasma membrane or by a change in the number of transport proteins on the cell surface. The effect of cAMP on basolateral abundance of NBC was assessed semi-quantitatively using confocal microscopy. cell surface expression with greater precision, the effect of 15-min treatment with 100 M 8-bromo-cAMP on cell surface expression of NBC was determined by cell surface biotinylation. As shown in Fig. 7 , the amount of cell surface NBC as a percentage of total cellular NBC was not altered by cAMP in NHERF-(1-355)-expressing BSC-1 cells. As determined by densitometry measurements, the ratio of cell surface to total NBC after 15 min of cAMP divided by the ratio of cell surface to total NBC in control cells averaged 1.06 Ϯ 0.07% (n ϭ 3, p ϭ NS).
DISCUSSION
Recent cellular and biochemical experiments have established that NHERF functions to facilitate the formation of a signal complex of proteins, including ezrin and PKA that results in the phosphorylation of NHE3 resident in the plasma membrane and the subsequent acute down-regulation of its activity (1) (2) (3) (4) . NHERF contains two tandem PDZ domains and an ezrin-radixin-moesin-merlin binding domain in the C-terminal end of the protein (1) . In vitro and in vivo studies established that NHERF binds to NHE3 and that NHERF requires a physical linkage to ezrin to function in PKA-mediated inhibition of NHE3 (2, 3) . Studies by Bernardo et al. (10) in association with our laboratory advanced in vitro evidence using a reconstitution assay and in vivo evidence using BSC-1 cells that PKA-mediated inhibition of NBC also has an absolute requirement for NHERF. Aside from these initial observations, little is known about the interaction between NBC and NHERF. The present studies, therefore, were designed to detail the interaction between NHERF and NBC in cAMP-mediated inhibition of NBC.
The present experiments confirm prior studies and indicate that NBC activity is not regulated by cAMP in wild-type BSC-1 cells but is inhibited by over 30% in cells expressing mouse NHERF-(1-355). Expression of PDZ II, including the C terminus of NHERF (mNHERF-(116 -355)) mimicked the function of the full-length protein whereas PDZ I (mNHERF-(1-126)) did not support cAMP-mediated inhibition of NBC. NHERF lacking the ERM binding domain (mNHERF-(1-325)) also did not support cAMP-mediated inhibition of NBC. Thus, PDZ II and the ERM domain of NHERF are the minimal requirements for transducing cAMP inhibition of NBC activity. These structurefunction studies of the interaction of NHERF with NBC resemble the structural determinants required for transducing cAMP signals that inhibit NHE3 (2, 3) .
Prior studies established that cAMP-associated inhibition of NHE3 was characterized by the binding of NHE3 and NHERF, and by NHERF-mediated phosphorylation of NHE3 itself (2).
To determine if the model proposed for this regulatory pathway could be generalized to that between NHERF and NBC, we determined the biochemical association between these two proteins as pertains to cAMP regulation of NBC. The interaction between NBC and NHERF was studied initially using a yeast two-hybrid assay. Although NHERF and NBC stimulated gene transcription 3-to 5-fold above background, the extent of stimulation was very modest as compared with the 300-fold or higher stimulation when NHERF and the C terminus of NHE3 were used as bait and prey. To exclude the possibility that, unlike the C terminus of NHE3, NBC did not acquire an appropriate conformation to bind NHERF in the two-hybrid assay, we analyzed the association of the wild-type proteins expressed in BSC-1 cells. Using an antibody to either NBC or NHERF, we were unable to co-immunoprecipitate NHERF and NBC from mNHERF-(1-355)-expressing BSC-1 cells. Using confocal microscopy, we attempted to co-localize NHERF and NBC in mNHERF-(1-355)-expressing BSC-1 cells using two different antibodies to each protein. Expression of NHERF did not affect the cellular distribution of NBC. NBC was detected predominantly in the basolateral membranes of the cells as confirmed by the distribution of Na ϩ -K ϩ -ATPase. NHERF was expressed in the apical and basolateral membranes and throughout the cytosol of the transfected BSC-1 cells. We were unable, however, to demonstrate co-localization NHERF and NBC in these cells either in the absence or after treatment with cAMP. In preliminary studies, we were also unable to demonstrate co-localization of endogenous NBC and NHERF in the basolateral membrane of rat renal proximal convoluted cells. Thus, when considered together, it seems unlikely that NHERF and NBC bind one another with any avidity in vivo.
NBC contains one or more potential PKA, protein kinase C, and casein kinase phosphorylation sites in its C terminus (20, 21) . NBC immunoprecipitated as a phosphoprotein from metabolically labeled wild-type and mNHERF-(1-355)-expressing BSC-1 cells, but the degree of phosphorylation was not increased by treatment with cAMP in either cell line. In addition, PKA did not directly phosphorylate NBC immunoprecipitated from wild-type or mNHERF-(1-355)-expressing BSC-1 cells under control conditions or after treatment with cAMP. It would appear, then, that NBC is a phosphoprotein in unstimulated BSC-1 cells but that cAMP does not alter its phosphorylation state. It is not known at this time if the lack of PKAmediated phosphorylation of NBC represents prior phosphorylation of putative PKA sites on the C terminus of NBC by other protein kinases or the unavailability of this site to PKA by virtue of the structure of the protein. These findings highlight, in a general sense, the need to directly demonstrate the phosphorylation of potential protein kinase target sites before proposing mechanisms based on amino acid sequences alone. The lack of binding of NBC to NHERF and the inability of NHERF to facilitate the phosphorylation of NBC are in contrast to the role of NHERF in its interaction with NHE3 (2, 3) .
Given that cAMP affected NBC activity without phosphorylating the transporter itself, we explored the possibility that NHERF was the target of PKA. Although recombinant NHERF is a substrate for PKA in vitro, NHERF is constitutively phosphorylated in vivo and its phosphorylation is not increased by cAMP (2, 22, 23) . Recent studies have identified G protein receptor kinase 6A as the endogenous "NHERF kinase" and determined that this kinase phosphorylates serine residue 289 of rabbit NHERF (18) . Point mutations of serine 289 to alanine, however, did not alter the ability of cAMP to inhibit NHE3 (2). To ensure that there was not a sub-cellular pool of NHERF uniquely phosphorylated by cAMP, a non-phosphorylated form of rabbit NHERF containing the S289A mutation was ex- pressed in the BSC-1 cells. This protein also supported cAMP inhibition of NBC activity. These results indicate that neither NBC nor NHERF is the critical substrate of cAMP in its regulation of NBC activity in BSC-1 cells.
NBC transport activity can be altered by biochemical modification of transporters resident in the plasma membrane or by a change in the number of transporters expressed on the cell surface. As determined by confocal microcopy and biotinylation experiments, cell surface expression of NBC was not altered by 15 min of treatment with cAMP. In turn, these results suggest that the acute inhibitory effect of cAMP on NBC activity is the consequence of a biochemical modification of the NBC transporter itself. Direct phosphorylation of the substrate protein is the most common mechanism for this form of biochemical modification. In the present case, however, the evidence indicates that NBC is not phosphorylated by cAMP. We would suggest, therefore, that cAMP-associated inhibition of NBC activity is the result of biochemical modification of the NBC transporter by a process that involves the interaction of NBC with other cAMP-activated proteins. Although the nature of these other reactive proteins remains to be determined, this postulated mechanism has previously been discussed by Moe (19) in consideration of the mechanism of cAMP inhibition of NHE3.
In summary, the present experiments demonstrate that NHERF is a necessary co-factor in cAMP-mediated inhibition of NBC activity in BSC-1 cells and that regulation requires the ERM domain of the NHERF protein. NBC and NHERF do not bind to one another and NHERF does not mediate the phosphorylation of NBC. In mNHERF-(1-355)-expressing BSC-1 cells, cAMP does not alter the cell surface expression of NBC over the time course of 15 min. Thus, the mechanism whereby NHERF is required for cAMP inhibition of NBC activity is distinct from previously characterized NHERF-mediated signal transduction pathways such as that associated with cAMP inhibition of NHE3. Based on the results of the current experiments, we suggest that there are other unique PKA-activated proteins that modify the activity of NBC present in the plasma membrane.
